These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25973092)
21. Enhanced generation of endothelial cells from CD34+ cells of the bone marrow in rheumatoid arthritis: possible role in synovial neovascularization. Hirohata S; Yanagida T; Nampei A; Kunugiza Y; Hashimoto H; Tomita T; Yoshikawa H; Ochi T Arthritis Rheum; 2004 Dec; 50(12):3888-96. PubMed ID: 15593185 [TBL] [Abstract][Full Text] [Related]
22. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Klimek E; Skalska A; Kwaśny-Krochin B; Surdacki A; Sulicka J; Korkosz M; Fedak D; Kierzkowska I; Wizner B; Grodzicki TK Mediators Inflamm; 2014; 2014():681635. PubMed ID: 24864133 [TBL] [Abstract][Full Text] [Related]
23. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease. Meinkoth JH; Meyers KM Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study. Lutf A; Poil AR; Hammoudeh M Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269 [TBL] [Abstract][Full Text] [Related]
25. Effects of percutaneous lower-extremity arterial interventions on endothelial function and inflammation response in patients with both type 2 diabetes and lower-extremity peripheral arterial disease. Du Y; Wang F; Qi H; Ding H; Hou L; Gao Q; Tan M; Liu Y; Xing N; Sun J Int J Clin Exp Pathol; 2015; 8(7):8115-21. PubMed ID: 26339379 [TBL] [Abstract][Full Text] [Related]
26. A New Explanation of Inflammation in Rheumatoid Arthritis Patients With Respect to Claudin-5, Matrix Metalloproteinase-9, and Neuroserpin. Tamer SA; Gürol G; Tekeoğlu İ; Harman H; Çiftçi İH Arch Rheumatol; 2016 Dec; 31(4):299-305. PubMed ID: 30375560 [TBL] [Abstract][Full Text] [Related]
27. von Willebrand factor in the plasma of patients with rheumatic diseases. Duţu A; Rus V; Boloşiu HD; Parasca I; Cristea A; Malide D Med Interne; 1989; 27(4):273-8. PubMed ID: 2617082 [TBL] [Abstract][Full Text] [Related]
32. Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Freestone B; Gustafsson F; Chong AY; Corell P; Kistorp C; Hildebrandt P; Lip GY Chest; 2008 May; 133(5):1203-8. PubMed ID: 18339785 [TBL] [Abstract][Full Text] [Related]
33. [The association of von Willebrand factor and von Willebrand factor-cleaving protease in systemic lupus erythematosus]. Lu GY; Guo XF; Wang ZY; Bai X; Su J; Ruan CG Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):42-4. PubMed ID: 16624087 [TBL] [Abstract][Full Text] [Related]
34. Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report. Shahmohamadnejad S; Vaisi-Raygani A; Shakiba Y; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Pourmotabbed T Clin Biochem; 2015 Jan; 48(1-2):63-9. PubMed ID: 25179377 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation. Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715 [TBL] [Abstract][Full Text] [Related]
36. Decreased immunoreactivity of von Willebrand factor may reflect persistent nature of the endothelial dysfunction in non-ischemic heart failure. Reichman-Warmusz E; Brzozowa-Zasada M; Wojciechowska C; Dudek D; Warmusz O; Wojnicz R Folia Histochem Cytobiol; 2021; 59(2):108-113. PubMed ID: 34003485 [TBL] [Abstract][Full Text] [Related]
37. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. Wieczorek I; Ludlam CA; MacGregor IR Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304 [TBL] [Abstract][Full Text] [Related]
38. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318 [TBL] [Abstract][Full Text] [Related]